Locations:
SearchAdvertisement
Collaborative approach may reduce distress caused by neuropsychiatric symptoms
A principal investigator of the landmark longitudinal study shares interesting observations to date
Results may refine surgical selection criteria and advance clinical trial design
Depression, agitation, delusions and more compound challenges for patients and caregivers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Systems genetics approach sets stage for lab testing of simvastatin and other candidate drugs
Sustained remission of seizures and neurocognitive dysfunction subsequently maintained with cannabidiol monotherapy
Modest research progress to date can still be turned into meaningful patient gains
No effect on symptom severity or disability, and low prevalence of long COVID
Comprehensive treatment harnesses power of pharmacologic and behavioral therapies
Novel approach begins reinnervation before tumor resection, preserving a young woman’s smile
Advertisement
Advertisement